AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Pluri Inc.

Board/Management Information Jul 19, 2021

6990_rns_2021-07-19_fd676b9a-4c87-428e-ae17-966135e8b4e8.htm

Board/Management Information

Open in Viewer

Opens in native device viewer

8k - Appointment of new Directors false

�������� ��������� ���� 2 380
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001 8543
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 19/07/2021
www.isa.gov.il www.tase.co.il Reference: 2021-02-118884 Time of broadcast: 14:36 14:27:14

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on8k - Appointment of new Directors

ea144418-8k_pluristemEDGAR1_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 15/06/2021
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected]   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: Chief Executive Officer, Director Name of Employer Company:
Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.